Las Vegas, NV -- (SBWIRE) -- 12/16/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: WidePoint Corporation (NYSEMKT:WYY), Real Goods Solar, Inc. (NASDAQ:RSOL), Cross Country Healthcare, Inc. (NASDAQ:CCRN), Generex Biotechnology Corporation (OTCMKTS:GNBT)
WidePoint Corporation (NYSEMKT:WYY) managed to keep its gain at 0.69% on above-normal volume of 1.56M shares. The stock settled at $1.46 after floating in a range of $1.42 to $1.50. Its latest price has reached market capitalization of $93.23 million. Its 52-week range has been $0.32 to $1.50. WidePoint Corporation provides technology-based products and solutions to government sector and commercial markets primarily in the United States. It operates in three segments: Communications Management, Cybersecurity Solutions, and Consulting Services and Products.
For How Long WYY will fight for Profitability? Read This Trend Analysis report
Real Goods Solar, Inc. (NASDAQ:RSOL) traded down on a volume of 3.53 million, higher than its standard daily volume. Shares have dropped-11.46% to $2.24. Over the last twelve months, the stock has gained 148.59% and faced a worst price of $0.50. Real Goods Solar, Inc. operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States. It provides commercial and residential solar energy solutions.
Has RSOL Found The Bottom And Ready To Gain Momentum? Find Out Here
Cross Country Healthcare, Inc. (NASDAQ:CCRN) settled 5.71% higher at $7.77 on above-normal volume of 384,959.00 shares during the last trading day. The stock has its 12-month high at $7.79 and 52-week low price was $4.32. It traded in a range of $7.33 to $7.79 during the last trading day. Cross Country Healthcare, Inc. provides nurse, allied and physician staffing services, and workforce solutions to the healthcare market in the United States. It operates through three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services.
Why Should Investors Buy CCRN After the Recent Fall? Just Go Here and Find Out
In the last trading session, Generex Biotechnology Corporation (OTCMKTS:GNBT) was up on low volume, trading at a volume of 723,409.00 versus its average daily volume of 1.83 million shares. At $0.02797, the stock has attained market capitalization of 17.24 million. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)